Federated Hermes, Inc. Homology Medicines, Inc. Transaction History

Federated Hermes, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.09 - $2.04 $106 - $199	98 Added 50.78%	291 $0
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $299 - $580	193 New	193 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.39 - $3.12 $8,352 - $18,748	-6,009 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.6 - $4.17 $10,257 - $16,450	-3,945 Reduced 39.63%	6,009 $18,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $35,952 - $76,843	9,877 Added 12827.27%	9,954 $36,000

Q3 2021 Nov 15, 2021	SELL	$6.01 - $8.71 $2.56 Million - $3.72 Million	-426,749 Reduced 99.98%	77 $1,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $2.57 Million - $4.11 Million	426,826 New	426,826 $3.1 Million
Q2 2019 Aug 14, 2019	SELL	$18.35 - $30.34 $2,275 - $3,762	-124 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$19.76 - $29.57 $197 - $295	-10 Reduced 7.46%	124 $3,000
Q4 2018 Feb 13, 2019	SELL	$18.39 - $26.3 $275 - $394	-15 Reduced 10.07%	134 $0
Q3 2018 Nov 13, 2018	BUY	$15.54 - $22.86 $2,315 - $3,406	149 New	149 $3,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.